These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 35658237
1. A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation. Fang J, Wu H, Zhang J, Mao S, Shi H, Yu D, Chen Z, Su K, Xing Y, Dong H, Shi H. Biomed Pharmacother; 2022 Jun; 150():113071. PubMed ID: 35658237 [Abstract] [Full Text] [Related]
4. Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolism. Kim HJ, Pandit A, Oh GS, Shen A, Lee SB, Khadka D, Lee S, Shim H, Yang SH, Cho EY, Kwak TH, Choe SK, Park R, So HS. Hear Res; 2016 Mar; 333():235-246. PubMed ID: 26341473 [Abstract] [Full Text] [Related]
7. Nicotinamide riboside, an NAD+ precursor, attenuates inflammation and oxidative stress by activating sirtuin 1 in alcohol-stimulated macrophages. Kang H, Park YK, Lee JY. Lab Invest; 2021 Sep; 101(9):1225-1237. PubMed ID: 33846538 [Abstract] [Full Text] [Related]
8. The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea. García-Alcántara F, Murillo-Cuesta S, Pulido S, Bermúdez-Muñoz JM, Martínez-Vega R, Milo M, Varela-Nieto I, Rivera T. Hear Res; 2018 Feb; 358():10-21. PubMed ID: 29304389 [Abstract] [Full Text] [Related]